Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000524017 | SCV000617276 | pathogenic | not provided | 2021-01-18 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28794150, 18205204, 19748572, 30283818) |
Eurofins Ntd Llc |
RCV000524017 | SCV000860804 | pathogenic | not provided | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000524017 | SCV004292605 | pathogenic | not provided | 2024-02-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp65*) in the DGUOK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DGUOK are known to be pathogenic (PMID: 18205204). This variant is present in population databases (rs140307681, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with mitochondrial DNA depletion syndrome (PMID: 18205204). ClinVar contains an entry for this variant (Variation ID: 449312). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005034066 | SCV005659356 | pathogenic | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4; Portal hypertension, noncirrhotic, 1 | 2024-02-18 | criteria provided, single submitter | clinical testing |